Atrinsic Inc. (PTIX) vs Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI)

Atrinsic Inc. and Scinai Immunotherapeutics Ltd. Sponsored ADR are both Biotechnology companies. Atrinsic Inc. and Scinai Immunotherapeutics Ltd. Sponsored ADR are of similar size ($1.3M and $1.2M). Scinai Immunotherapeutics Ltd. Sponsored ADR trades at the lower P/E: 0.0× against 0.3×. Across the 11 metrics below, Scinai Immunotherapeutics Ltd. Sponsored ADR leads on 7 and Atrinsic Inc. on 4.

Valuation

Metric PTIX SCNI Biotechnology median
P/E 0.35 0.02 7.88
P/S n/m n/m 11.47
P/B 0.82 0.10 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.22 0.74
EV/Sales n/m n/m 10.73
Earnings yield 285.90% 5,500.91% (28.84%)
Free cash flow yield (152.63%) (1,128.14%) (23.03%)

Profitability

Metric PTIX SCNI Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (338.24%) 0.00% (57.72%)
Return on assets 390.69% 0.00% (49.22%)
Return on invested capital (229.86%) 0.00% 0.00%

Growth

Metric PTIX SCNI Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 188.24% (159.83%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PTIX SCNI Biotechnology median
Debt to equity 0.00 0.02 0.00
Current ratio 0.66 1.56 4.73
Net debt to EBITDA 0.52 0.25 0.96

Dividend

Metric PTIX SCNI Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric PTIX SCNI Biotechnology median
Market cap 1.27m 1.20m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack